Clinical Trial Center (CTC)/Centrum foer klinisk proevning

Gothenburg 413 45

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Disease, Hyperlipidemia

Studies at this site

• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early